Table of Content

1 Study Coverage
1.1 Ultra Short Acting Insulin Product Introduction
1.2 Market by Type
1.2.1 Global Ultra Short Acting Insulin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Insulin Lispro
1.2.3 Insulin Aspart
1.2.4 Insulin Glulisine
1.3 Market by Application
1.3.1 Global Ultra Short Acting Insulin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.3.4 Gestational Diabetes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Ultra Short Acting Insulin Sales Estimates and Forecasts 2018-2029
2.2 Global Ultra Short Acting Insulin Revenue by Region
2.2.1 Global Ultra Short Acting Insulin Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Ultra Short Acting Insulin Revenue by Region (2018-2024)
2.2.3 Global Ultra Short Acting Insulin Revenue by Region (2024-2029)
2.2.4 Global Ultra Short Acting Insulin Revenue Market Share by Region (2018-2029)
2.3 Global Ultra Short Acting Insulin Sales Estimates and Forecasts 2018-2029
2.4 Global Ultra Short Acting Insulin Sales by Region
2.4.1 Global Ultra Short Acting Insulin Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Ultra Short Acting Insulin Sales by Region (2018-2024)
2.4.3 Global Ultra Short Acting Insulin Sales by Region (2024-2029)
2.4.4 Global Ultra Short Acting Insulin Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Ultra Short Acting Insulin Sales by Manufacturers
3.1.1 Global Ultra Short Acting Insulin Sales by Manufacturers (2018-2024)
3.1.2 Global Ultra Short Acting Insulin Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ultra Short Acting Insulin in 2022
3.2 Global Ultra Short Acting Insulin Revenue by Manufacturers
3.2.1 Global Ultra Short Acting Insulin Revenue by Manufacturers (2018-2024)
3.2.2 Global Ultra Short Acting Insulin Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Ultra Short Acting Insulin Revenue in 2022
3.3 Global Key Players of Ultra Short Acting Insulin, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Ultra Short Acting Insulin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Ultra Short Acting Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Ultra Short Acting Insulin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Ultra Short Acting Insulin, Product Offered and Application
3.8 Global Key Manufacturers of Ultra Short Acting Insulin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Ultra Short Acting Insulin Sales by Type
4.1.1 Global Ultra Short Acting Insulin Historical Sales by Type (2018-2024)
4.1.2 Global Ultra Short Acting Insulin Forecasted Sales by Type (2024-2029)
4.1.3 Global Ultra Short Acting Insulin Sales Market Share by Type (2018-2029)
4.2 Global Ultra Short Acting Insulin Revenue by Type
4.2.1 Global Ultra Short Acting Insulin Historical Revenue by Type (2018-2024)
4.2.2 Global Ultra Short Acting Insulin Forecasted Revenue by Type (2024-2029)
4.2.3 Global Ultra Short Acting Insulin Revenue Market Share by Type (2018-2029)
4.3 Global Ultra Short Acting Insulin Price by Type
4.3.1 Global Ultra Short Acting Insulin Price by Type (2018-2024)
4.3.2 Global Ultra Short Acting Insulin Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Ultra Short Acting Insulin Sales by Application
5.1.1 Global Ultra Short Acting Insulin Historical Sales by Application (2018-2024)
5.1.2 Global Ultra Short Acting Insulin Forecasted Sales by Application (2024-2029)
5.1.3 Global Ultra Short Acting Insulin Sales Market Share by Application (2018-2029)
5.2 Global Ultra Short Acting Insulin Revenue by Application
5.2.1 Global Ultra Short Acting Insulin Historical Revenue by Application (2018-2024)
5.2.2 Global Ultra Short Acting Insulin Forecasted Revenue by Application (2024-2029)
5.2.3 Global Ultra Short Acting Insulin Revenue Market Share by Application (2018-2029)
5.3 Global Ultra Short Acting Insulin Price by Application
5.3.1 Global Ultra Short Acting Insulin Price by Application (2018-2024)
5.3.2 Global Ultra Short Acting Insulin Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Ultra Short Acting Insulin Market Size by Type
6.1.1 US & Canada Ultra Short Acting Insulin Sales by Type (2018-2029)
6.1.2 US & Canada Ultra Short Acting Insulin Revenue by Type (2018-2029)
6.2 US & Canada Ultra Short Acting Insulin Market Size by Application
6.2.1 US & Canada Ultra Short Acting Insulin Sales by Application (2018-2029)
6.2.2 US & Canada Ultra Short Acting Insulin Revenue by Application (2018-2029)
6.3 US & Canada Ultra Short Acting Insulin Market Size by Country
6.3.1 US & Canada Ultra Short Acting Insulin Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Ultra Short Acting Insulin Sales by Country (2018-2029)
6.3.3 US & Canada Ultra Short Acting Insulin Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Ultra Short Acting Insulin Market Size by Type
7.1.1 Europe Ultra Short Acting Insulin Sales by Type (2018-2029)
7.1.2 Europe Ultra Short Acting Insulin Revenue by Type (2018-2029)
7.2 Europe Ultra Short Acting Insulin Market Size by Application
7.2.1 Europe Ultra Short Acting Insulin Sales by Application (2018-2029)
7.2.2 Europe Ultra Short Acting Insulin Revenue by Application (2018-2029)
7.3 Europe Ultra Short Acting Insulin Market Size by Country
7.3.1 Europe Ultra Short Acting Insulin Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Ultra Short Acting Insulin Sales by Country (2018-2029)
7.3.3 Europe Ultra Short Acting Insulin Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Ultra Short Acting Insulin Market Size
8.1.1 China Ultra Short Acting Insulin Sales (2018-2029)
8.1.2 China Ultra Short Acting Insulin Revenue (2018-2029)
8.2 China Ultra Short Acting Insulin Market Size by Application
8.2.1 China Ultra Short Acting Insulin Sales by Application (2018-2029)
8.2.2 China Ultra Short Acting Insulin Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Ultra Short Acting Insulin Market Size by Type
9.1.1 Asia Ultra Short Acting Insulin Sales by Type (2018-2029)
9.1.2 Asia Ultra Short Acting Insulin Revenue by Type (2018-2029)
9.2 Asia Ultra Short Acting Insulin Market Size by Application
9.2.1 Asia Ultra Short Acting Insulin Sales by Application (2018-2029)
9.2.2 Asia Ultra Short Acting Insulin Revenue by Application (2018-2029)
9.3 Asia Ultra Short Acting Insulin Sales by Region
9.3.1 Asia Ultra Short Acting Insulin Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Ultra Short Acting Insulin Revenue by Region (2018-2029)
9.3.3 Asia Ultra Short Acting Insulin Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Ultra Short Acting Insulin Market Size by Type
10.1.1 Middle East, Africa and Latin America Ultra Short Acting Insulin Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Ultra Short Acting Insulin Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Ultra Short Acting Insulin Market Size by Application
10.2.1 Middle East, Africa and Latin America Ultra Short Acting Insulin Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Ultra Short Acting Insulin Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Ultra Short Acting Insulin Sales by Country
10.3.1 Middle East, Africa and Latin America Ultra Short Acting Insulin Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Ultra Short Acting Insulin Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Ultra Short Acting Insulin Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Information
11.1.2 Eli Lilly and Company Overview
11.1.3 Eli Lilly and Company Ultra Short Acting Insulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Eli Lilly and Company Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Eli Lilly and Company Recent Developments
11.2 Gan & Lee Pharmaceuticals
11.2.1 Gan & Lee Pharmaceuticals Company Information
11.2.2 Gan & Lee Pharmaceuticals Overview
11.2.3 Gan & Lee Pharmaceuticals Ultra Short Acting Insulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Gan & Lee Pharmaceuticals Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Gan & Lee Pharmaceuticals Recent Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Information
11.3.2 Novo Nordisk Overview
11.3.3 Novo Nordisk Ultra Short Acting Insulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Novo Nordisk Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novo Nordisk Recent Developments
11.4 Wockhardt
11.4.1 Wockhardt Company Information
11.4.2 Wockhardt Overview
11.4.3 Wockhardt Ultra Short Acting Insulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Wockhardt Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Wockhardt Recent Developments
11.5 Ypsomed
11.5.1 Ypsomed Company Information
11.5.2 Ypsomed Overview
11.5.3 Ypsomed Ultra Short Acting Insulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Ypsomed Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Ypsomed Recent Developments
11.6 Tonghua Dongbao
11.6.1 Tonghua Dongbao Company Information
11.6.2 Tonghua Dongbao Overview
11.6.3 Tonghua Dongbao Ultra Short Acting Insulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Tonghua Dongbao Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Tonghua Dongbao Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Overview
11.7.3 Sanofi Ultra Short Acting Insulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Sanofi Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sanofi Recent Developments
11.8 United Laboratory
11.8.1 United Laboratory Company Information
11.8.2 United Laboratory Overview
11.8.3 United Laboratory Ultra Short Acting Insulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 United Laboratory Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 United Laboratory Recent Developments
11.9 Jiangsu Wanbang
11.9.1 Jiangsu Wanbang Company Information
11.9.2 Jiangsu Wanbang Overview
11.9.3 Jiangsu Wanbang Ultra Short Acting Insulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Jiangsu Wanbang Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Jiangsu Wanbang Recent Developments
11.10 B. Braun
11.10.1 B. Braun Company Information
11.10.2 B. Braun Overview
11.10.3 B. Braun Ultra Short Acting Insulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 B. Braun Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 B. Braun Recent Developments
11.11 Becton, Dickinson
11.11.1 Becton, Dickinson Company Information
11.11.2 Becton, Dickinson Overview
11.11.3 Becton, Dickinson Ultra Short Acting Insulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Becton, Dickinson Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Becton, Dickinson Recent Developments
11.12 Biocon
11.12.1 Biocon Company Information
11.12.2 Biocon Overview
11.12.3 Biocon Ultra Short Acting Insulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Biocon Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Biocon Recent Developments
11.13 Biodel
11.13.1 Biodel Company Information
11.13.2 Biodel Overview
11.13.3 Biodel Ultra Short Acting Insulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Biodel Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Biodel Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Ultra Short Acting Insulin Industry Chain Analysis
12.2 Ultra Short Acting Insulin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Ultra Short Acting Insulin Production Mode & Process
12.4 Ultra Short Acting Insulin Sales and Marketing
12.4.1 Ultra Short Acting Insulin Sales Channels
12.4.2 Ultra Short Acting Insulin Distributors
12.5 Ultra Short Acting Insulin Customers
13 Market Dynamics
13.1 Ultra Short Acting Insulin Industry Trends
13.2 Ultra Short Acting Insulin Market Drivers
13.3 Ultra Short Acting Insulin Market Challenges
13.4 Ultra Short Acting Insulin Market Restraints
14 Key Findings in The Global Ultra Short Acting Insulin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Ultra Short Acting Insulin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Insulin Lispro
Table 3. Major Manufacturers of Insulin Aspart
Table 4. Major Manufacturers of Insulin Glulisine
Table 5. Global Ultra Short Acting Insulin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Ultra Short Acting Insulin Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Ultra Short Acting Insulin Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Ultra Short Acting Insulin Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Ultra Short Acting Insulin Revenue Market Share by Region (2018-2024)
Table 10. Global Ultra Short Acting Insulin Revenue Market Share by Region (2024-2029)
Table 11. Global Ultra Short Acting Insulin Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Ultra Short Acting Insulin Sales by Region (2018-2024) & (Tons)
Table 13. Global Ultra Short Acting Insulin Sales by Region (2024-2029) & (Tons)
Table 14. Global Ultra Short Acting Insulin Sales Market Share by Region (2018-2024)
Table 15. Global Ultra Short Acting Insulin Sales Market Share by Region (2024-2029)
Table 16. Global Ultra Short Acting Insulin Sales by Manufacturers (2018-2024) & (Tons)
Table 17. Global Ultra Short Acting Insulin Sales Share by Manufacturers (2018-2024)
Table 18. Global Ultra Short Acting Insulin Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Ultra Short Acting Insulin Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Ultra Short Acting Insulin, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Ultra Short Acting Insulin Price by Manufacturers 2018-2024 (US$/Ton)
Table 22. Global Ultra Short Acting Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Ultra Short Acting Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ultra Short Acting Insulin as of 2022)
Table 24. Global Key Manufacturers of Ultra Short Acting Insulin, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Ultra Short Acting Insulin, Product Offered and Application
Table 26. Global Key Manufacturers of Ultra Short Acting Insulin, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Ultra Short Acting Insulin Sales by Type (2018-2024) & (Tons)
Table 29. Global Ultra Short Acting Insulin Sales by Type (2024-2029) & (Tons)
Table 30. Global Ultra Short Acting Insulin Sales Share by Type (2018-2024)
Table 31. Global Ultra Short Acting Insulin Sales Share by Type (2024-2029)
Table 32. Global Ultra Short Acting Insulin Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Ultra Short Acting Insulin Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Ultra Short Acting Insulin Revenue Share by Type (2018-2024)
Table 35. Global Ultra Short Acting Insulin Revenue Share by Type (2024-2029)
Table 36. Ultra Short Acting Insulin Price by Type (2018-2024) & (US$/Ton)
Table 37. Global Ultra Short Acting Insulin Price Forecast by Type (2024-2029) & (US$/Ton)
Table 38. Global Ultra Short Acting Insulin Sales by Application (2018-2024) & (Tons)
Table 39. Global Ultra Short Acting Insulin Sales by Application (2024-2029) & (Tons)
Table 40. Global Ultra Short Acting Insulin Sales Share by Application (2018-2024)
Table 41. Global Ultra Short Acting Insulin Sales Share by Application (2024-2029)
Table 42. Global Ultra Short Acting Insulin Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Ultra Short Acting Insulin Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Ultra Short Acting Insulin Revenue Share by Application (2018-2024)
Table 45. Global Ultra Short Acting Insulin Revenue Share by Application (2024-2029)
Table 46. Ultra Short Acting Insulin Price by Application (2018-2024) & (US$/Ton)
Table 47. Global Ultra Short Acting Insulin Price Forecast by Application (2024-2029) & (US$/Ton)
Table 48. US & Canada Ultra Short Acting Insulin Sales by Type (2018-2024) & (Tons)
Table 49. US & Canada Ultra Short Acting Insulin Sales by Type (2024-2029) & (Tons)
Table 50. US & Canada Ultra Short Acting Insulin Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Ultra Short Acting Insulin Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Ultra Short Acting Insulin Sales by Application (2018-2024) & (Tons)
Table 53. US & Canada Ultra Short Acting Insulin Sales by Application (2024-2029) & (Tons)
Table 54. US & Canada Ultra Short Acting Insulin Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Ultra Short Acting Insulin Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Ultra Short Acting Insulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Ultra Short Acting Insulin Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Ultra Short Acting Insulin Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Ultra Short Acting Insulin Sales by Country (2018-2024) & (Tons)
Table 60. US & Canada Ultra Short Acting Insulin Sales by Country (2024-2029) & (Tons)
Table 61. Europe Ultra Short Acting Insulin Sales by Type (2018-2024) & (Tons)
Table 62. Europe Ultra Short Acting Insulin Sales by Type (2024-2029) & (Tons)
Table 63. Europe Ultra Short Acting Insulin Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Ultra Short Acting Insulin Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Ultra Short Acting Insulin Sales by Application (2018-2024) & (Tons)
Table 66. Europe Ultra Short Acting Insulin Sales by Application (2024-2029) & (Tons)
Table 67. Europe Ultra Short Acting Insulin Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Ultra Short Acting Insulin Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Ultra Short Acting Insulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Ultra Short Acting Insulin Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Ultra Short Acting Insulin Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Ultra Short Acting Insulin Sales by Country (2018-2024) & (Tons)
Table 73. Europe Ultra Short Acting Insulin Sales by Country (2024-2029) & (Tons)
Table 74. China Ultra Short Acting Insulin Sales by Type (2018-2024) & (Tons)
Table 75. China Ultra Short Acting Insulin Sales by Type (2024-2029) & (Tons)
Table 76. China Ultra Short Acting Insulin Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Ultra Short Acting Insulin Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Ultra Short Acting Insulin Sales by Application (2018-2024) & (Tons)
Table 79. China Ultra Short Acting Insulin Sales by Application (2024-2029) & (Tons)
Table 80. China Ultra Short Acting Insulin Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Ultra Short Acting Insulin Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Ultra Short Acting Insulin Sales by Type (2018-2024) & (Tons)
Table 83. Asia Ultra Short Acting Insulin Sales by Type (2024-2029) & (Tons)
Table 84. Asia Ultra Short Acting Insulin Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Ultra Short Acting Insulin Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Ultra Short Acting Insulin Sales by Application (2018-2024) & (Tons)
Table 87. Asia Ultra Short Acting Insulin Sales by Application (2024-2029) & (Tons)
Table 88. Asia Ultra Short Acting Insulin Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Ultra Short Acting Insulin Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Ultra Short Acting Insulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Ultra Short Acting Insulin Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Ultra Short Acting Insulin Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Ultra Short Acting Insulin Sales by Region (2018-2024) & (Tons)
Table 94. Asia Ultra Short Acting Insulin Sales by Region (2024-2029) & (Tons)
Table 95. Middle East, Africa and Latin America Ultra Short Acting Insulin Sales by Type (2018-2024) & (Tons)
Table 96. Middle East, Africa and Latin America Ultra Short Acting Insulin Sales by Type (2024-2029) & (Tons)
Table 97. Middle East, Africa and Latin America Ultra Short Acting Insulin Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Ultra Short Acting Insulin Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Ultra Short Acting Insulin Sales by Application (2018-2024) & (Tons)
Table 100. Middle East, Africa and Latin America Ultra Short Acting Insulin Sales by Application (2024-2029) & (Tons)
Table 101. Middle East, Africa and Latin America Ultra Short Acting Insulin Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Ultra Short Acting Insulin Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Ultra Short Acting Insulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Ultra Short Acting Insulin Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Ultra Short Acting Insulin Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Ultra Short Acting Insulin Sales by Country (2018-2024) & (Tons)
Table 107. Middle East, Africa and Latin America Ultra Short Acting Insulin Sales by Country (2024-2029) & (Tons)
Table 108. Eli Lilly and Company Company Information
Table 109. Eli Lilly and Company Description and Major Businesses
Table 110. Eli Lilly and Company Ultra Short Acting Insulin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 111. Eli Lilly and Company Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Eli Lilly and Company Recent Developments
Table 113. Gan & Lee Pharmaceuticals Company Information
Table 114. Gan & Lee Pharmaceuticals Description and Major Businesses
Table 115. Gan & Lee Pharmaceuticals Ultra Short Acting Insulin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 116. Gan & Lee Pharmaceuticals Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Gan & Lee Pharmaceuticals Recent Developments
Table 118. Novo Nordisk Company Information
Table 119. Novo Nordisk Description and Major Businesses
Table 120. Novo Nordisk Ultra Short Acting Insulin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 121. Novo Nordisk Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Novo Nordisk Recent Developments
Table 123. Wockhardt Company Information
Table 124. Wockhardt Description and Major Businesses
Table 125. Wockhardt Ultra Short Acting Insulin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 126. Wockhardt Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Wockhardt Recent Developments
Table 128. Ypsomed Company Information
Table 129. Ypsomed Description and Major Businesses
Table 130. Ypsomed Ultra Short Acting Insulin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 131. Ypsomed Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Ypsomed Recent Developments
Table 133. Tonghua Dongbao Company Information
Table 134. Tonghua Dongbao Description and Major Businesses
Table 135. Tonghua Dongbao Ultra Short Acting Insulin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 136. Tonghua Dongbao Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Tonghua Dongbao Recent Developments
Table 138. Sanofi Company Information
Table 139. Sanofi Description and Major Businesses
Table 140. Sanofi Ultra Short Acting Insulin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 141. Sanofi Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Sanofi Recent Developments
Table 143. United Laboratory Company Information
Table 144. United Laboratory Description and Major Businesses
Table 145. United Laboratory Ultra Short Acting Insulin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 146. United Laboratory Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. United Laboratory Recent Developments
Table 148. Jiangsu Wanbang Company Information
Table 149. Jiangsu Wanbang Description and Major Businesses
Table 150. Jiangsu Wanbang Ultra Short Acting Insulin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 151. Jiangsu Wanbang Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Jiangsu Wanbang Recent Developments
Table 153. B. Braun Company Information
Table 154. B. Braun Description and Major Businesses
Table 155. B. Braun Ultra Short Acting Insulin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 156. B. Braun Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. B. Braun Recent Developments
Table 158. Becton, Dickinson Company Information
Table 159. Becton, Dickinson Description and Major Businesses
Table 160. Becton, Dickinson Ultra Short Acting Insulin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 161. Becton, Dickinson Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Becton, Dickinson Recent Developments
Table 163. Biocon Company Information
Table 164. Biocon Description and Major Businesses
Table 165. Biocon Ultra Short Acting Insulin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 166. Biocon Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Biocon Recent Developments
Table 168. Biodel Company Information
Table 169. Biodel Description and Major Businesses
Table 170. Biodel Ultra Short Acting Insulin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 171. Biodel Ultra Short Acting Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Biodel Recent Developments
Table 173. Key Raw Materials Lists
Table 174. Raw Materials Key Suppliers Lists
Table 175. Ultra Short Acting Insulin Distributors List
Table 176. Ultra Short Acting Insulin Customers List
Table 177. Ultra Short Acting Insulin Market Trends
Table 178. Ultra Short Acting Insulin Market Drivers
Table 179. Ultra Short Acting Insulin Market Challenges
Table 180. Ultra Short Acting Insulin Market Restraints
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
List of Figures
Figure 1. Ultra Short Acting Insulin Product Picture
Figure 2. Global Ultra Short Acting Insulin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Ultra Short Acting Insulin Market Share by Type in 2022 & 2029
Figure 4. Insulin Lispro Product Picture
Figure 5. Insulin Aspart Product Picture
Figure 6. Insulin Glulisine Product Picture
Figure 7. Global Ultra Short Acting Insulin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Ultra Short Acting Insulin Market Share by Application in 2022 & 2029
Figure 9. Type 1 Diabetes
Figure 10. Type 2 Diabetes
Figure 11. Gestational Diabetes
Figure 12. Ultra Short Acting Insulin Report Years Considered
Figure 13. Global Ultra Short Acting Insulin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Ultra Short Acting Insulin Revenue 2018-2029 (US$ Million)
Figure 15. Global Ultra Short Acting Insulin Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Ultra Short Acting Insulin Revenue Market Share by Region (2018-2029)
Figure 17. Global Ultra Short Acting Insulin Sales 2018-2029 ((Tons)
Figure 18. Global Ultra Short Acting Insulin Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Ultra Short Acting Insulin Sales YoY (2018-2029) & (Tons)
Figure 20. US & Canada Ultra Short Acting Insulin Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Ultra Short Acting Insulin Sales YoY (2018-2029) & (Tons)
Figure 22. Europe Ultra Short Acting Insulin Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Ultra Short Acting Insulin Sales YoY (2018-2029) & (Tons)
Figure 24. China Ultra Short Acting Insulin Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Ultra Short Acting Insulin Sales YoY (2018-2029) & (Tons)
Figure 26. Asia (excluding China) Ultra Short Acting Insulin Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Ultra Short Acting Insulin Sales YoY (2018-2029) & (Tons)
Figure 28. Middle East, Africa and Latin America Ultra Short Acting Insulin Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Ultra Short Acting Insulin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Ultra Short Acting Insulin in the World: Market Share by Ultra Short Acting Insulin Revenue in 2022
Figure 31. Global Ultra Short Acting Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Ultra Short Acting Insulin Sales Market Share by Type (2018-2029)
Figure 33. Global Ultra Short Acting Insulin Revenue Market Share by Type (2018-2029)
Figure 34. Global Ultra Short Acting Insulin Sales Market Share by Application (2018-2029)
Figure 35. Global Ultra Short Acting Insulin Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Ultra Short Acting Insulin Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Ultra Short Acting Insulin Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Ultra Short Acting Insulin Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Ultra Short Acting Insulin Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Ultra Short Acting Insulin Revenue Share by Country (2018-2029)
Figure 41. US & Canada Ultra Short Acting Insulin Sales Share by Country (2018-2029)
Figure 42. U.S. Ultra Short Acting Insulin Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Ultra Short Acting Insulin Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Ultra Short Acting Insulin Sales Market Share by Type (2018-2029)
Figure 45. Europe Ultra Short Acting Insulin Revenue Market Share by Type (2018-2029)
Figure 46. Europe Ultra Short Acting Insulin Sales Market Share by Application (2018-2029)
Figure 47. Europe Ultra Short Acting Insulin Revenue Market Share by Application (2018-2029)
Figure 48. Europe Ultra Short Acting Insulin Revenue Share by Country (2018-2029)
Figure 49. Europe Ultra Short Acting Insulin Sales Share by Country (2018-2029)
Figure 50. Germany Ultra Short Acting Insulin Revenue (2018-2029) & (US$ Million)
Figure 51. France Ultra Short Acting Insulin Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Ultra Short Acting Insulin Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Ultra Short Acting Insulin Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Ultra Short Acting Insulin Revenue (2018-2029) & (US$ Million)
Figure 55. China Ultra Short Acting Insulin Sales Market Share by Type (2018-2029)
Figure 56. China Ultra Short Acting Insulin Revenue Market Share by Type (2018-2029)
Figure 57. China Ultra Short Acting Insulin Sales Market Share by Application (2018-2029)
Figure 58. China Ultra Short Acting Insulin Revenue Market Share by Application (2018-2029)
Figure 59. Asia Ultra Short Acting Insulin Sales Market Share by Type (2018-2029)
Figure 60. Asia Ultra Short Acting Insulin Revenue Market Share by Type (2018-2029)
Figure 61. Asia Ultra Short Acting Insulin Sales Market Share by Application (2018-2029)
Figure 62. Asia Ultra Short Acting Insulin Revenue Market Share by Application (2018-2029)
Figure 63. Asia Ultra Short Acting Insulin Revenue Share by Region (2018-2029)
Figure 64. Asia Ultra Short Acting Insulin Sales Share by Region (2018-2029)
Figure 65. Japan Ultra Short Acting Insulin Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Ultra Short Acting Insulin Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Ultra Short Acting Insulin Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Ultra Short Acting Insulin Revenue (2018-2029) & (US$ Million)
Figure 69. India Ultra Short Acting Insulin Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Ultra Short Acting Insulin Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Ultra Short Acting Insulin Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Ultra Short Acting Insulin Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Ultra Short Acting Insulin Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Ultra Short Acting Insulin Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Ultra Short Acting Insulin Sales Share by Country (2018-2029)
Figure 76. Brazil Ultra Short Acting Insulin Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Ultra Short Acting Insulin Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Ultra Short Acting Insulin Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Ultra Short Acting Insulin Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Ultra Short Acting Insulin Revenue (2018-2029) & (US$ Million)
Figure 81. Ultra Short Acting Insulin Value Chain
Figure 82. Ultra Short Acting Insulin Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed